Glaucoma Eye Drops Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	144 Pages	Coherent Market Insights	July, 2023	CMI18107875

Best Price Guarantee
Price	from $4,500
Length	144 Pages
Publisher	Coherent Market Insights
Published Date	July, 2023
SKU	CMI18107875

Glaucoma Eye Drops Market, by Drug Type (Prostaglandin analogs, Beta blockers, Alpha agonists, Carbonic Anhydrase Inhibitors (CAIs), Combined Medications and Others (rho-kinase inhibitor, Cholinergic agonist), by Disease Indication (Angle-closure Glaucoma and Open-angle Glaucoma), By Distribution Channel (Hospital Pharmacy Retail Pharmacy and Online Pharmacy), by Composition (Preservative Free, BAK-Based and Non BAK-Based Preservatives), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Glaucoma is a group of eye diseases that can cause vision loss and blindness by damaging a nerve in the back of your eye called the optic nerve. The symptoms can start so slowly that a patient may not notice them. The only way to find out if a person has glaucoma is to get a comprehensive dilated eye exam. Glaucoma may occur among people with or without diabetes. Moreover, people with diabetic retinopathy have an increased risk of glaucoma. The condition is associated with abnormal blood vessel growth, which can result in retinopathy and leads to blockage of natural drainage of the eye. Rapidly increasing geriatric population is one of the important factors for the increasing prevalence of glaucoma, which in turn is projected to drive the growth of the glaucoma therapeutics market in the near future.

Market Dynamics

The global glaucoma eye drops market is expected to witness significant growth during the forecast period owing to the increasing prevalence of glaucoma. For instance, according to the Centre for Disease Control and Prevention, in November 2020, an estimated 3 Mn people suffered from blindness due to glaucoma in the U.S. 2020.

Key features of the study:

This report provides in-depth analysis of the global glaucoma eye drops market, market size (US$ Mn), and compound annual growth rate (CAGR (%) for the forecast period: 2023-2030, considering 2022 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global glaucoma eye drops market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Merck KGaA, Allergan plc ( A subsidiary of AbbVie Inc.), Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Bausch & Lomb, Inotek, Jadran-galenski laboratorij d.d. JGL d.d, Aerie Pharmaceutical (A subsidiary of Alcon Management S. A) and Mylan N.V (A subsidiary of Viatris Inc.)
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics.
The global glaucoma eye drops market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for glaucoma eye drops, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

Global Glaucoma Eye Drops Market, By Drug Type:
Prostaglandin analogs
Beta blockers
Alpha agonists
Carbonic Anhydrase Inhibitors (CAIs)
Combined Medications
Others (rho-kinase inhibitor, Cholinergic agonist)
Global Glaucoma Eye Drops Market, By Disease Indication:
Angle-closure Glaucoma
Open-angle Glaucoma
Global Glaucoma Eye Drops Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Glaucoma Eye Drops Market, By Composition:
Preservative Free
BAK-Based
Non BAK-Based Preservatives
Global Glaucoma Eye Drops Market, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Company Profiles
Merck KGaA
Allergan plc ( A subsidiary of AbbVie Inc)
Novartis AG
Teva Pharmaceutical Industries Ltd.
Pfizer, Inc.
Bausch & Lomb
Inotek
Jadran-galenski laboratorij d.d. JGL d.d
Aerie Pharmaceutical (A subsidiary of Alcon Management S. A)
Mylan N.V. (A subsidiary of Viatris Inc.)

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Drug Type; Market Snapshot, By Disease Indication; Market Snapshot, By Distribution Channel; Market Snapshot, By Composition; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Recent Product Launches; Epidemiology; Merger, Acquisition, and Collaboration; Regulatory Scenario; Key Developments; PEST Analysis
4. Global Glaucoma Eye Drops Market– COVID-19 Impact Analysis: Economic Impact; COVID-19 Epidemiology; Impact on Supply and Demand
5. Global Glaucoma Eye Drops Market, By Drug Type, 2018–2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Prostaglandin analogs; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); Beta blockers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); Alpha agonists; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); Carbonic Anhydrase Inhibitors (CAIs); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); Combined Medications; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
6. Global Glaucoma Eye Drops Market, By Disease Indication, 2018–2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Angle-closure Glaucoma; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); Open-angle Glaucoma; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
7. Global Glaucoma Eye Drops Market, By Distribution Channel, 2018–2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Hospital Pharmacy; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); Retail Pharmacy; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); Online Pharmacy; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
8. Global Glaucoma Eye Drops Market, By Composition, 2018–2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Preservative Free; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); BAK-Based; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn); Non BAK-Based Preservatives; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
9. Global Glaucoma Eye Drops Market, By Region, 2018–2030, (US$ Million): Introduction; Market Share Analysis, By Region, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Regions, 2018–2030; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Composition, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Composition, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Composition, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Composition, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Composition, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Composition, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million); North Africa; Central Africa; South Africa
10. Competitive Landscape: Merck KGaA; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Allergan plc ( A subsidiary of AbbVie Inc); Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Novartis AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Teva Pharmaceutical Industries Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Pfizer, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Bausch & Lomb; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Inotek; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Jadran-galenski laboratorij d.d. JGL d.d; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Aerie Pharmaceutical (A subsidiary of Alcon Management S. A); Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Mylan N.V. (A subsidiary of Viatris Inc.); Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies
11. Section: Research Methodology; About Us; *Browse 43 market data tables and 37 figures on “Glaucoma Eye Drops Market” - Global forecast to 2030